Hepatitis C Care Pathway Associated With Increased Screening, Confirmation, and Diagnosis Communication to Patients
- 1 March 2021
- journal article
- letter
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 19 (3) , 607-609.e2
Abstract
No abstract availableKeywords
Funding Information
- Kaiser Permanente
- National Institutes of Health
- Kaiser Foundation Research Institute
- Patient-Centered Outcomes Research Institute
- Gordon and Betty Moore Foundation
- Kaiser Permanente
This publication has 6 references indexed in Scilit:
- Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby BoomersOpen Forum Infectious Diseases, 2017
- Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic StatesClinical Infectious Diseases, 2016
- Improving Hepatitis C Virus Screening Rates in Primary CareJournal for Healthcare Quality, 2015
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised studyThe Lancet, 2014
- The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-AnalysisPLOS ONE, 2014
- Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2013